Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 p53 Activation by small molecules: application in oncology.

× No keyword cloud information.

56 in total

1. Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.

Authors: Drew D Dudgeon; Sunita N Shinde; Tong Ying Shun; John S Lazo; Christopher J Strock; Kenneth A Giuliano; D Lansing Taylor; Patricia A Johnston; Paul A Johnston
Journal: Assay Drug Dev Technol Date: 2010-08 Impact factor: 1.738

2. A small-molecule inhibitor of MDMX activates p53 and induces apoptosis.

Authors: Hongbo Wang; Xujun Ma; Shumei Ren; John K Buolamwini; Chunhong Yan
Journal: Mol Cancer Ther Date: 2010-11-12 Impact factor: 6.261

3. Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.

Authors: Erica M Walsh; MengMeng Niu; Johann Bergholz; Zhi-Xiong Jim Xiao
Journal: Biochem Biophys Res Commun Date: 2015-04-12 Impact factor: 3.575

4. Protein-protein interactions for cancer therapy.

Authors: Curtis C Harris
Journal: Proc Natl Acad Sci U S A Date: 2006-02-01 Impact factor: 11.205

5. A small-molecule p53 activator induces apoptosis through inhibiting MDMX expression in breast cancer cells.

Authors: Hongbo Wang; Chunhong Yan
Journal: Neoplasia Date: 2011-07 Impact factor: 5.715

6. Beta-peptides with improved affinity for hDM2 and hDMX.

Authors: Elizabeth A Harker; Douglas S Daniels; Danielle A Guarracino; Alanna Schepartz
Journal: Bioorg Med Chem Date: 2009-01-23 Impact factor: 3.641

7. Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale.

Authors: Tyler A Davis; Anna E Vilgelm; Ann Richmond; Jeffrey N Johnston
Journal: J Org Chem Date: 2013-10-15 Impact factor: 4.354

8. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Authors: Kensuke Kumamoto; Elisa A Spillare; Kaori Fujita; Izumi Horikawa; Taro Yamashita; Ettore Appella; Makoto Nagashima; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal: Cancer Res Date: 2008-05-01 Impact factor: 12.701

Review 9. The alpha,alpha-difluorinated phosphonate L-pSer-analogue: an accessible chemical tool for studying kinase-dependent signal transduction.

Authors: Kaushik Panigrahi; MariJean Eggen; Jun-Ho Maeng; Quanrong Shen; David B Berkowitz
Journal: Chem Biol Date: 2009-09-25

10. TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.

Authors: Shinako Araki; Jacob A Eitel; Christopher N Batuello; Khadijeh Bijangi-Vishehsaraei; Xian-Jin Xie; David Danielpour; Karen E Pollok; David A Boothman; Lindsey D Mayo
Journal: J Clin Invest Date: 2009-12-01 Impact factor: 14.808